Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$17K Sell
2,718
-19,038
-88% -$208K ﹤0.01% 8192
2014
Q2
$317K Sell
21,756
-42,242
-66% -$643K ﹤0.01% 4676
2014
Q1
$1.26M Buy
63,998
+16,553
+35% +$344K ﹤0.01% 3255
2013
Q4
$887K Sell
47,445
-16,325
-26% -$224K ﹤0.01% 3678
2013
Q3
$845K Buy
63,770
+38,189
+149% +$479K ﹤0.01% 3540
2013
Q2
$226K Buy
+25,581
New +$254K ﹤0.01% 4962

Other funds holding FRO

UBS's FRO Position: Q3 2014 in Review

UBS reduced its Frontline (FRO) stake by 88% in Q3 2014, selling an estimated $208K and leaving 2,718 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #8192.

UBS first reported a position in FRO in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.26M in Q1 2014. 83 funds tracked by Wall St. Rank hold FRO as of Q3 2014.

  • UBS held 2,718 shares of Frontline worth $17K as of Q3 2014.
  • UBS sold 19,038 Frontline shares in Q3 2014, an estimated $208K.
  • Frontline made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8192 holding.
  • UBS first reported a position in Frontline in Q2 2013 and has held it in 6 quarters since.
  • UBS's Frontline position peaked at $1.26M in Q1 2014.
  • 83 funds tracked by Wall St. Rank held Frontline as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.